performed a prospective trial in which they showed that the age of the uterus did not affect the outcome of pregnancy Lister Hospital, Chelsea Bridge Road, London SW1W 8RH, UK when oocytes were taken from the same donor and randomly 1 To whom correspondence should be addressed allocated to recipients below and above the age of 40. There have been two subsequent reports contradicting these findings, The importance of age of the recipient (uterine age) with
allocated to recipients below and above the age of 40. There have been two subsequent reports contradicting these findings, The importance of age of the recipient (uterine age) with showing that an age-related decline in fecundity could also be regards to pregnancy rate, delivery rate and miscarriage related to uterine receptivity affecting either implantation rate rate following oocyte donation was evaluated using (Borini et al., 1996) or miscarriage rate (Cano et al., 1995) . retrospective data analysis of cases where two recipients
In an attempt to clarify this situation we have retrospectively from different age groups shared oocytes from a single analysed all our egg donation cycles in which oocytes taken donor and had equal numbers of embryos transferred. A from one donor were shared between younger and older total of 104 women (21-52 years of age) underwent a total recipients. We used strict criteria for inclusion in the study. of 104 cycles of oocyte donation. They were divided into groups according to age (group A: age 39 years or less and group B: age between 40 and 52 years). The minimum age Materials and methods difference between a pair of recipients was five years.
The recipients included in the study all received egg donation Hormone replacement therapy (HRT) was given using at the Lister Hospital between January 1, 1988 and December oestradiol valerate (6 mg daily) for at least 10 days, 31, 1995. The criteria for choosing a pair of recipients were followed by a combination of oestradiol with either intraas follows: both must have shared oocytes from the same muscular progesterone (100 mg daily), or vaginally donor. One recipient was aged 39 or less, the other 40 or administered micronized progesterone (300 µg daily).
above, with at least five years between them. Both recipients Women with ovarian function received down-regulation received a similar number of eggs (a maximum difference of using a luteinizing hormone-releasing hormone (LHRH) one egg). Both had a similar fertilization rate and had the analogue before hormone replacement was commenced. A same number of embryos transferred (all fresh cycles). total of 52 transfer cycles was performed in each age All the donors were between 25 and 35 years and each group and pregnancy, delivery and miscarriage rates were provided oocytes for two recipients. They all received ovarian analysed as outcome measures; 20 pregnancies were stimulation using intranasal Buserelin (Suprefact ® , Hoechst, achieved in each group (an identical pregnancy rate of Hounslow, UK) in combination with human menopausal 38.5%). In group A seven pregnancies miscarried out of gonadotrophins as described previously (Abdalla et al., 1990) . 20 (35%), which was not significantly different from the All recipients awaiting oocyte donation were maintained on rate in the older population, group B, where eight out of a hormone replacement therapy (HRT) regimen which has 20 pregnancies miscarried (40%). The delivery rate in been described previously (Abdalla et al., 1990) . Patients with group A was 25% (13 out of 52), again not significantly normal ovarian function had no HRT supplementation in their different from the delivery rate in group B of 23.1% (12 non-treatment cycles; however, in the cycle in which they had out of 52). In conclusion, using egg donation as a model, the embryos transferred, their ovarian function was suppressed the decline in fecundity with age cannot be explained by using the gonadotrophin-releasing hormone (GnRH) analogue uterine factors alone.
Buserelin as a nasal spray (100 µg every 4 h from day 1 of Key words: hormone replacement therapy/implantation rate/ the cycle) together with HRT in the dose described previously oocyte donation/uterine age (Abdalla et al., 1990) . The route of transfer was then determined by the state of the Fallopian tubes. Tubal transfer was performed if both tubes were patent, otherwise intrauterine embryo Introduction transfer was performed. In all cases transfer was performed after 3-4 days' progesterone supplementation. There is a significant decline in human fecundity with advancing age. There is also a concomitant decline in success
The results were analysed in terms of the pregnancy rate and the outcome of these pregnancies in the two age groups. rate following infertility treatment, including in-vitro fertilization (Cano et al., 1995) . This reproductive failure could be Statistical analysis was performed using a χ 2 test to examine the difference in the pregnancy rate between the two groups. due to either uterine or ovarian factors. Oocyte donation provides a good model in which to examine these two Student's t test was used to examine the differences in the mean values. factors independently. Utilizing this model, Navot et al. (l994) H.I.Abdalla et al. Navot et al. (1994) found that there was no significant Cano et al. (1995) found that both pregnancy and implantaOocytes 5.9 (Ϯ 1.3) 5.6 (Ϯ 1.3) NS tion rates were not significantly different in the two age groups. donated range (3-9) range (3-8) (mean Ϯ SD) However, they reported a significantly higher miscarriage rate are affected by age.
(mean Ϯ SD) Borini et al. (1996) found that the pregnancy and implanta- might influence the results in the older population. All the oocytes were randomly allocated between the groups. However, in our opinion, this was not sufficient since the fertilization rate may also differ between the groups for a variety of other Results reasons. We therefore included only patients who had similar A total of 899 cycles of fresh oocyte donation was performed fertilization rates and, more importantly, who had an identical at the Lister Hospital between January 1, 1988 and December number of embryos transferred. Since age is a continuum we 31, 1995. Of these 315 (35%) resulted in a pregnancy and 211 did not include recipients of closer ages. We only considered (23.5%) resulted in a live birth. We were able to select 52 those pairs with a minimum age difference of five years to pairs (104 patient cycles) which met the criteria outlined in accentuate any effect of the age of the uterus. Methods. Table I shows the results of this study and, as we
In our study the pregnancy rate in the two groups was expected, the only statistically significant difference between identical. However, the wide confidence interval of 19% due the groups was age of recipient. As shown, the pregnancy rate to the small sample size must be noted. The take home rate of 38.5% was identical in the two groups (20 out of 52 in was also very similar. This suggests that the pregnancy, each group); the 95% confidence interval was (Ϫ19.1, ϩ 19.1).
implantation and miscarriage rates were independent of the There was no significant difference in the implantation rate in age of the uterus. These findings are almost identical to those the two groups. The delivery rate was also very similar, 13 reported by Navot et al. (1994) in their prospective trial. They out of 52 (25%) in group A and 12 out of 52 (23.1%) in group are also similar to the other prospective trial by Cano et al. B. In group A there were 10 singleton deliveries, 2 sets of (1995) in terms of pregnancy and implantation rates. Only the twins and 1 set of triplets and in group B there were 9 singleton results published by Borini et al. (1996) showed a lower deliveries and 3 sets of twins.
pregnancy rate in the older group. Utilizing a regression model we have previously shown that Discussion there was no significant effect of age of the uterus on either pregnancy rate or implantation rate (Abdalla et al., 1993) . We Age-related decline in fecundity is a fact. The important question, however, is whether this is due to uterine-or ovarianhave also found that the age of the donor (oocyte) was directly correlated to an increase in miscarriage rate. Levran et al. associated factors. Oocyte donation provides a unique model in which the contribution of uterine and oocyte factors can be (1991) also found that the age of the donor was correlated with the spontaneous abortion rate. Cano et al. (1995) undertook the separated. Since oocytes are provided by a different person, the effect of the uterus (age of patient) can be considered only study that showed a much higher miscarriage rate in older recipients (48%) which was independent of the age of independently.
There are conflicting reports in the literature about the agethe donor.
It is important to recognize, however, that the uterus also related decline in fecundity. Only three other reports have analysed this question with a similar study design (namely, contributes to implantation; Borini et al. (1995) found a reduction in pregnancy rate if women remained cyclical oocytes from a single donor randomly allocated to two recipients below and above the age of 40). Two were prospeccompared to those who had been down-regulated before HRT supplementation. Michalas et al. (1996) described a flexible tive (Navot et al., 1994; Cano et al., 1995) and one was retrospective (Borini et al., 1996) . approach for preparing the endometrium and showed that administration of oestradiol from 6-11 days is sufficient to prepare the endometrium. Both these studies clearly suggest a uterine role in implantation. Our data, however, suggest that this role does not seem to be affected by age. We conclude that the decline in fecundity with age cannot be explained by uterine factors alone. The age-related rise in miscarriage rate is due to an egg factor although the contribution of uterine factors cannot be completely excluded.
